Nebenwirkungen · Rivastigmine 1 A Pharma
Rivastigmine 1 A Pharma 2 mg/ml oral solution · Abschnitt 4.8 · PDF-Seite 23
HOS-212464 · Präparat HOS-154894
Metabolism and nutrition disorders Common Decreased appetite Common Dehydration Psychiatric disorders Common Insomnia Common Anxiety Common Restlessness Common Hallucination, visual Common Depression Not known Aggression Nervous system disorders Very common Tremor Common Dizziness Common Somnolence Common Headache Common Parkinson’s disease (worsening) Common Bradykinesia Common Dyskinesia Common Hypokinesia Common Cogwheel rigidity Uncommon Dystonia Not known Pleurothotonus (Pisa syndrome) Cardiac disorders Common Bradycardia Uncommon Arial fibrillation Uncommon Atrioventricular block Not known Sick sinus syndrome Vascular disorders Common Hypertension Uncommon Hypotension Gastrointestinal disorders Very common Nausea Very common Vomiting Common Diarrhoea Common Abdominal pain and dyspepsia Common Salivary hypersecretion Hepatobiliary disorders Not known Hepatitis Skin and subcutaneous tissue disorders Common Hyperhydrosis
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-20T13:50:00Z · SHA-256 131a9504ea601ff9f929650be1df38b3f3e958ac8aed8146800bb83c92474fa3 · Passage ae7c8a447a65a999a457dbcd28f97060c90fcca68b04b9e834209cb7a2450492 · Zeichen 4756–7201 im Abschnitt